This Human Monoclonal antibody specifically detects LILRA4 (Daxdilimab Biosimilar) in . It exhibits reactivity toward Human.
Catalog No. ABIN7597617
Quick Overview for Recombinant LILRA4 (Daxdilimab Biosimilar) antibody (ABIN7597617)
Target
LILRA4 (Daxdilimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This LILRA4 (Daxdilimab Biosimilar) antibody is un-conjugated
Grade
Research Grade
Expression System
Mammalian cells
Purpose
Research Grade Daxdilimab Biosimilar Antibody
Specificity
CD85g, ILT7, Immunoglobulin-like transcript 7, LILRA4, Leukocyte immunoglobulin-like receptor subfamily A member 4, ILT-7, CD85 antigen-like family member G
Purification
Protein A or G purified from cell culture supernatant.
Research Grade
Reactivity: Human
Host: CHO Cells
Monoclonal
unconjugated
Recombinant Antibody
Restrictions
For Research Use only
Format
Liquid
Concentration
5.12 mg/mL
Buffer
0.01M PBS, pH 7.4.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Expiry Date
12 months
Target
LILRA4 (Daxdilimab Biosimilar)
Alternative Name
Daxdilimab Biosimilar
Target Type
Biosimilar
Background
CD85g, ILT7, Immunoglobulin-like transcript 7, LILRA4, Leukocyte immunoglobulin-like receptor subfamily A member 4, ILT-7, CD85 antigen-like family member G